Reconnecting Practicing Hygienists with the Nation's Leading Educators and Researchers.

J&J Begins Human Trials of Its One-Dose COVID-19 Vaccine

After data demonstrated Johnson and Johnson’s (J&J) one-dose vaccine offered significant protection against COVID-19 in monkeys, the pharmaceutical giant started human trials on July 30. The initial trial includes 1,000 adults in both the United States and Belgium. If these data show safety and efficacy, the company plans to begin large-scale human trials in September. Testing on a two-shot vaccine is also underway. J&J has received more than $450 million from the federal government to support its COVID-19 vaccine development efforts. Read more here.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy